Wzorest Pharma And Chemicals Private Limited
Founded in 2016 and headquartered in Maharashtra, India.
2016 | Thane, Maharashtra (India) | Active
Wzorest Pharma And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 11 Months
About Wzorest Pharma And Chemicals
Wzorest Pharma And Chemicals Private Limited (WPACPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 March 2016 (Eight years and 11 months 13 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Aditya Dabholkar, Abhijeet Dev, Amol Badhe, and One other member serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51102MH2016PTC274431
- Company No.
274431
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 2016
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Business Services
Who are the key members and board of directors at Wzorest Pharma And Chemicals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijeet Dev  | Director | 15-Mar-2016 | Current |
| Aditya Dabholkar | Additional Director | 18-Mar-2016 | Current |
| Amol Badhe | Director | 15-Mar-2016 | Current |
| Narendra Deore | Director | 15-Mar-2016 | Current |
Financial Performance of Wzorest Pharma And Chemicals.
Enhance accessibility to Wzorest Pharma And Chemicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Wzorest Pharma And Chemicals?
Unlock access to Wzorest Pharma And Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Kevi Life Sciences Llp
Aditya Dabholkar is a mutual person
- Devrudra Realcon Private Limited
Narendra Deore is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wzorest Pharma And Chemicals?
Unlock and access historical data on people associated with Wzorest Pharma And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wzorest Pharma And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wzorest Pharma And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.